Notice From The Executive Officer

RE: Important Notice Regarding Change in Funding Status of Oxycodone Controlled Release Tablet – (Discontinuation of OxyContin and introduction of OxyNEO)
Author(s): 
Ontario Public Drug Programs Division
Source: 
Government of Ontario
Region: